Proteomics Market

Description

The proteomics market is anticipated to grow significantly, with projections indicating an increase from US$ 34.56 billion in 2024 to US$ 85.91 billion by 2031, reflecting a CAGR of 11.9% from 2025 to 2031.

Analyst Perspective:This report outlines growth opportunities based on current trends in the proteomics market and their expected effects during the forecast period. Proteomics involves the extensive study of proteomes, which are collections of proteins produced by a biological entity. A proteome is dynamic, varying from one cell to another and changing over time. It provides insights into the underlying transcriptome, which encompasses all messenger RNA molecules in an organism. Various factors, beyond just gene expression levels, affect protein activity. The applications of proteomics are vast, and the market is projected to expand significantly due to rising demand for personalized medicine and increased research and development in the field. However, stringent regulatory requirements and a shortage of skilled professionals may hinder market growth.

Market Overview:Proteomics is the comprehensive study of protein structures and functions. It includes the rapidly advancing area of disease proteomics, which seeks to identify proteins associated with human diseases and understand how their expression, structure, and function contribute to disease. Key drivers of growth in the proteomics market include the rising incidence of cancer and other diseases. Ongoing proteomics research aids healthcare professionals in understanding protein behavior in dynamic environments, such as in cancer patients, by providing critical biomarker information. Moreover, advancements in nano proteomics are expected to positively influence market growth in the coming years.

Strategic Insights Market Driver: Rising Incidence of Chronic Diseases Fuels Market ExpansionThe increasing prevalence of chronic diseases, including cancer, respiratory illnesses, chronic kidney disease (CKD), and cardiovascular diseases (CVDs), is a significant factor anticipated to drive market growth. For instance, Globocan reported approximately 19.3 million new cancer cases globally in December 2020, with 10 million cancer-related deaths. Cardiovascular diseases are also among the leading causes of death worldwide, with the WHO (2021) noting that these diseases account for 41 million deaths annually. The rising incidence of life-threatening diseases is driving demand for personalized therapies, which positively impacts the industry.

As a significant portion of the global population battles cancer, the demand for effective treatments has surged. Numerous breakthroughs are being made in life sciences, with the characterization of human proteins marking a significant advancement in biomedicine. Evaluating gene expression at the proteome level is crucial. Ongoing research and development in this area are expected to lead to substantial growth in the proteomics market, as this technique can yield vital biological insights that enhance our understanding of cancer biology. The increasing prevalence of chronic diseases further amplifies the demand for proteomics.

Segmental Analysis:The analysis of the proteomics market has been conducted by examining the following segments: product & service, application, and end user.

In terms of product & service, the proteomics market is categorized into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment dominated the market in 2022 and is projected to achieve the highest CAGR of 14.1% from 2022 to 2030. This growth is attributed to the increasing utilization of reagents, kits, consumables, and strips for studying various biological materials in research institutions and universities. Additionally, government initiatives supporting proteomics and genomics, along with heightened research activities in disease diagnostics, are expected to drive market growth. Furthermore, advancements in sophisticated instruments, such as 3D electrophoresis protein analyzers, which enhance the speed, efficiency, and productivity of biological research, will also contribute to market expansion.

By application, the market is segmented into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest share of the proteomics market in 2022, as researchers and clinicians frequently utilize protein analysis to identify disease biomarkers for early risk factor detection. Proteomics-based diagnostics can also uncover potential protein transcription regulation, aiding in the identification and prognosis of malignancies.

Regarding end users, the proteomics market is divided into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, and others. The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2022. However, the research & clinical laboratories segment is expected to experience the highest CAGR of 14.5% from 2022 to 2030. Increased R&D funding from pharmaceutical and biotechnology firms aimed at developing innovative drugs is likely to drive demand for proteomics services. Additionally, the need for enzymes, reagents, and kits is being fueled by heightened research and development activities, ongoing proteomics studies targeting various life-threatening diseases, and increased life science projects in academic and research settings.

Regional Analysis:The proteomics market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North American market was valued at US$ 11.95 billion in 2022 and is projected to reach US$ 33.56 billion by 2030, with an expected CAGR of 13.8% from 2022 to 2030. Key factors driving market growth in this region include increased investments in structure-based drug design, demand for high-quality research tools for data reproducibility, and growth in omics research. There is a focus on developing personalized treatments, and partnerships among major regional companies also contribute to market expansion. For example, Thermo Fisher Scientific Inc. and Symphogen have collaborated to create verified platform processes for the optimized characterization and quality monitoring of complex therapeutic proteins. Numerous protein therapies are currently undergoing clinical trials for cancer, infections, immunological disorders, age-related diseases, and other conditions. Additionally, proteomics research is thriving in the US, driven by the high incidence of inherited diseases like Alzheimer's and infectious diseases such as malaria and tuberculosis in the region.

The Asia Pacific proteomics market is expected to exhibit the fastest CAGR of 14.3%. This region, particularly countries like India and China, boasts a substantial pharmaceutical industry, with China serving as a hub for pharmaceutical manufacturing. The anticipated market growth in this region is attributed to the presence of highly functional manufacturing units and contract manufacturing facilities. Furthermore, a large population susceptible to cancer and other infectious diseases, extensive use of proteomics in diagnosing genetic disorders, and increased R&D spending and social programs are expected to drive the demand for proteome-based disease diagnosis, thereby enhancing market growth.

Proteomics Market Report Scope Key Player Analysis:Key players profiled in the proteomics market report include Proteome Sciences, Biognosys, Creative Proteomics, Shantani, Olink, SomaLogic Operating Co., Inc., QUANTUM-SI INCORPORATED, Proteomics International, Promise Proteomics, SCIEX, Illumina, Inc., and Thermo Fisher Scientific Inc.

Recent Developments:Companies in the proteomics market are pursuing mergers and acquisitions as key growth strategies. Recent developments in the market include:

In June 2022, SomaLogic and Illumina, Inc. announced a joint development agreement to utilize the SomaScan Proteomics Assay on Illumina's current and future high-throughput next-generation sequencing (NGS) platforms, accelerating next-generation sequencing in the rapidly growing proteomics market.In May 2022, Proteomics International Laboratories Ltd secured US$ 13,516 in funding to facilitate the production of its PromarkerD clinical diagnostic in Australia, the first diagnostic predictive test for diabetes-related kidney disease. This initiative aims to foster new health innovations and advance discoveries toward proof-of-concept and commercialization that address significant health challenges and maximize entrepreneurial potential.

Product Code: TIPHE100001115

1. INTRODUCTION

1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
- 1.3.1 Proteomics Market - By Instrument
- 1.3.2 Proteomics Market - By Reagents
- 1.3.3 Proteomics Market - By Services and Software
- 1.3.4 Proteomics Market - By Application
- 1.3.5 Proteomics Market - By Region
  - 1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PROTEOMICS MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
- 4.2.1 North America - Pest Analysis
- 4.2.2 Europe - Pest Analysis
- 4.2.3 Asia-Pacific - Pest Analysis
- 4.2.4 Middle East and Africa - Pest Analysis
- 4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PROTEOMICS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROTEOMICS MARKET - GLOBAL MARKET ANALYSIS

6.1. PROTEOMICS - GLOBAL MARKET OVERVIEW
6.2. PROTEOMICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - INSTRUMENT

7.1. OVERVIEW
7.2. INSTRUMENT MARKET FORECASTS AND ANALYSIS
7.3. SPECTROSCOPY
- 7.3.1. Overview
- 7.3.2. Spectroscopy Market Forecast and Analysis
- 7.3.3. Mass Spectroscopy Market
  - 7.3.3.1. Overview
  - 7.3.3.2. Mass Spectroscopy Market Forecast and Analysis
- 7.3.4. NMR Spectroscopy Market
  - 7.3.4.1. Overview
  - 7.3.4.2. NMR Spectroscopy Market Forecast and Analysis
- 7.3.5. Circular Dichroism (CD) Spectroscopy Market
  - 7.3.5.1. Overview
  - 7.3.5.2. Circular Dichroism (CD) Spectroscopy Market Forecast and Analysis
7.4. CHROMATOGRAPHY
- 7.4.1. Overview
- 7.4.2. Chromatography Market Forecast and Analysis
- 7.4.3. HPLC Market
  - 7.4.3.1. Overview
  - 7.4.3.2. HPLC Market Forecast and Analysis
- 7.4.4. Ion Chromatography Market
  - 7.4.4.1. Overview
  - 7.4.4.2. Ion Chromatography Market Forecast and Analysis
- 7.4.5. Ion Chromatography Market
  - 7.4.5.1. Overview
  - 7.4.5.2. Ion Chromatography Market Forecast and Analysis
- 7.4.6. Supercritical Fluid Chromatography Market
  - 7.4.6.1. Overview
  - 7.4.6.2. Supercritical Fluid Chromatography Market Forecast and Analysis
7.5. ELECTROPHORESIS
- 7.5.1. Overview
- 7.5.2. Electrophoresis Market Forecast and Analysis
- 7.5.3. Gel Electrophoresis Market
  - 7.5.3.1. Overview
  - 7.5.3.2. Gel Electrophoresis Market Forecast and Analysis
- 7.5.4. Capillary Electrophoresis Market
  - 7.5.4.1. Overview
  - 7.5.4.2. Capillary Electrophoresis Market Forecast and Analysis
7.6. PROTEIN MICROARRAYS
- 7.6.1. Overview
- 7.6.2. Protein Microarrays Market Forecast and Analysis
- 7.6.3. Biochips Market
  - 7.6.3.1. Overview
  - 7.6.3.2. Biochips Market Forecast and Analysis
- 7.6.4. Microarray Instruments Market
  - 7.6.4.1. Overview
  - 7.6.4.2. Microarray Instruments Market Forecast and Analysis
7.7. X-RAY CRYSTALLOGRAPHY
- 7.7.1. Overview
- 7.7.2. X-Ray Crystallography Market Forecast and Analysis
7.8. SURFACE PLASMON RESONANCE
- 7.8.1. Overview
- 7.8.2. Surface Plasmon Resonance Market Forecast and Analysis
7.9. PROTEIN FRACTIONATION
- 7.9.1. Overview
- 7.9.2. Protein Fractionation Market Forecast and Analysis
7.10. OTHER INSTRUMENT
- 7.10.1. Overview
- 7.10.2. Other Instrument Market Forecast and Analysis

8. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - REAGENTS

8.1. OVERVIEW
8.2. REAGENTS MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOASSAY REAGENTS
- 8.3.1. Overview
- 8.3.2. Immunoassay Reagents Market Forecast and Analysis
8.4. SPECTROSCOPY REAGENTS
- 8.4.1. Overview
- 8.4.2. Spectroscopy Reagents Market Forecast and Analysis
8.5. CHROMATOGRAPHY REAGENTS
- 8.5.1. Overview
- 8.5.2. Chromatography Reagents Market Forecast and Analysis
8.6. PROTEIN MICROARRAY REAGENTS
- 8.6.1. Overview
- 8.6.2. Protein Microarray Reagents Market Forecast and Analysis
8.7. X-RAY CRYSTALLOGRAPHY REAGENTS
- 8.7.1. Overview
- 8.7.2. X-Ray Crystallography Reagents Market Forecast and Analysis
8.8. ELECTROPHORESIS REAGENTS
- 8.8.1. Overview
- 8.8.2. Electrophoresis Reagents Market Forecast and Analysis
8.9. PROTEIN FRACTIONATION REAGENTS
- 8.9.1. Overview
- 8.9.2. Protein Fractionation Reagents Market Forecast and Analysis

9. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES AND SOFTWARE

9.1. OVERVIEW
9.2. SERVICES AND SOFTWARE MARKET FORECASTS AND ANALYSIS
9.3. SERVICES
- 9.3.1. Overview
- 9.3.2. Services Market Forecast and Analysis
- 9.3.3. Protein Identification Services Market
  - 9.3.3.1. Overview
  - 9.3.3.2. Protein Identification Services Market Forecast and Analysis
- 9.3.4. Quantitative Proteomics Services Market
  - 9.3.4.1. Overview
  - 9.3.4.2. Quantitative Proteomics Services Market Forecast and Analysis
- 9.3.5. Protein Purification Services Market
  - 9.3.5.1. Overview
  - 9.3.5.2. Protein Purification Services Market Forecast and Analysis
- 9.3.6. Protein Separation Services Market
  - 9.3.6.1. Overview
  - 9.3.6.2. Protein Separation Services Market Forecast and Analysis
- 9.3.7. Protein Sequencing Services Market
  - 9.3.7.1. Overview
  - 9.3.7.2. Protein Sequencing Services Market Forecast and Analysis
- 9.3.8. Others Services Market
  - 9.3.8.1. Overview
  - 9.3.8.2. Others Services Market Forecast and Analysis
9.4. SOFTWARE
- 9.4.1. Overview
- 9.4.2. Software Market Forecast and Analysis
- 9.4.3. Bioinformatics Services Market
  - 9.4.3.1. Overview
  - 9.4.3.2. Bioinformatics Services Market Forecast and Analysis
- 9.4.4. Bioinformatics Tools Market
  - 9.4.4.1. Overview
  - 9.4.4.2. Bioinformatics Tools Market Forecast and Analysis
- 9.4.5. Bioinformatics Databases Market
  - 9.4.5.1. Overview
  - 9.4.5.2. Bioinformatics Databases Market Forecast and Analysis

10. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION

10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. CLINICAL DIAGNOSTICS
- 10.3.1. Overview
- 10.3.2. Clinical Diagnostics Market Forecast and Analysis
10.4. DRUG DISCOVERY
- 10.4.1. Overview
- 10.4.2. Drug Discovery Market Forecast and Analysis
10.5. OTHER APPLICATIONS
- 10.5.1. Overview
- 10.5.2. Other Applications Market Forecast and Analysis

11. PROTEOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS

11.1. NORTH AMERICA
- 11.1.1 North America Proteomics Market Overview
- 11.1.2 North America Proteomics Market Forecasts and Analysis
- 11.1.3 North America Proteomics Market Forecasts and Analysis - By Instrument
- 11.1.4 North America Proteomics Market Forecasts and Analysis - By Reagents
- 11.1.5 North America Proteomics Market Forecasts and Analysis - By Services and Software
- 11.1.6 North America Proteomics Market Forecasts and Analysis - By Application
- 11.1.7 North America Proteomics Market Forecasts and Analysis - By Countries
  - 11.1.7.1 United States Proteomics Market
    - 11.1.7.1.1 United States Proteomics Market by Instrument
    - 11.1.7.1.2 United States Proteomics Market by Reagents
    - 11.1.7.1.3 United States Proteomics Market by Services and Software
    - 11.1.7.1.4 United States Proteomics Market by Application
  - 11.1.7.2 Canada Proteomics Market
    - 11.1.7.2.1 Canada Proteomics Market by Instrument
    - 11.1.7.2.2 Canada Proteomics Market by Reagents
    - 11.1.7.2.3 Canada Proteomics Market by Services and Software
    - 11.1.7.2.4 Canada Proteomics Market by Application
  - 11.1.7.3 Mexico Proteomics Market
    - 11.1.7.3.1 Mexico Proteomics Market by Instrument
    - 11.1.7.3.2 Mexico Proteomics Market by Reagents
    - 11.1.7.3.3 Mexico Proteomics Market by Services and Software
    - 11.1.7.3.4 Mexico Proteomics Market by Application
11.2. EUROPE
- 11.2.1 Europe Proteomics Market Overview
- 11.2.2 Europe Proteomics Market Forecasts and Analysis
- 11.2.3 Europe Proteomics Market Forecasts and Analysis - By Instrument
- 11.2.4 Europe Proteomics Market Forecasts and Analysis - By Reagents
- 11.2.5 Europe Proteomics Market Forecasts and Analysis - By Services and Software
- 11.2.6 Europe Proteomics Market Forecasts and Analysis - By Application
- 11.2.7 Europe Proteomics Market Forecasts and Analysis - By Countries
  - 11.2.7.1 Germany Proteomics Market
    - 11.2.7.1.1 Germany Proteomics Market by Instrument
    - 11.2.7.1.2 Germany Proteomics Market by Reagents
    - 11.2.7.1.3 Germany Proteomics Market by Services and Software
    - 11.2.7.1.4 Germany Proteomics Market by Application
  - 11.2.7.2 France Proteomics Market
    - 11.2.7.2.1 France Proteomics Market by Instrument
    - 11.2.7.2.2 France Proteomics Market by Reagents
    - 11.2.7.2.3 France Proteomics Market by Services and Software
    - 11.2.7.2.4 France Proteomics Market by Application
  - 11.2.7.3 Italy Proteomics Market
    - 11.2.7.3.1 Italy Proteomics Market by Instrument
    - 11.2.7.3.2 Italy Proteomics Market by Reagents
    - 11.2.7.3.3 Italy Proteomics Market by Services and Software
    - 11.2.7.3.4 Italy Proteomics Market by Application
  - 11.2.7.4 Spain Proteomics Market
    - 11.2.7.4.1 Spain Proteomics Market by Instrument
    - 11.2.7.4.2 Spain Proteomics Market by Reagents
    - 11.2.7.4.3 Spain Proteomics Market by Services and Software
    - 11.2.7.4.4 Spain Proteomics Market by Application
  - 11.2.7.5 United Kingdom Proteomics Market
    - 11.2.7.5.1 United Kingdom Proteomics Market by Instrument
    - 11.2.7.5.2 United Kingdom Proteomics Market by Reagents
    - 11.2.7.5.3 United Kingdom Proteomics Market by Services and Software
    - 11.2.7.5.4 United Kingdom Proteomics Market by Application
  - 11.2.7.6 Rest of Europe Proteomics Market
    - 11.2.7.6.1 Rest of Europe Proteomics Market by Instrument
    - 11.2.7.6.2 Rest of Europe Proteomics Market by Reagents
    - 11.2.7.6.3 Rest of Europe Proteomics Market by Services and Software
    - 11.2.7.6.4 Rest of Europe Proteomics Market by Application
11.3. ASIA-PACIFIC
- 11.3.1 Asia-Pacific Proteomics Market Overview
- 11.3.2 Asia-Pacific Proteomics Market Forecasts and Analysis
- 11.3.3 Asia-Pacific Proteomics Market Forecasts and Analysis - By Instrument
- 11.3.4 Asia-Pacific Proteomics Market Forecasts and Analysis - By Reagents
- 11.3.5 Asia-Pacific Proteomics Market Forecasts and Analysis - By Services and Software
- 11.3.6 Asia-Pacific Proteomics Market Forecasts and Analysis - By Application
- 11.3.7 Asia-Pacific Proteomics Market Forecasts and Analysis - By Countries
  - 11.3.7.1 Australia Proteomics Market
    - 11.3.7.1.1 Australia Proteomics Market by Instrument
    - 11.3.7.1.2 Australia Proteomics Market by Reagents
    - 11.3.7.1.3 Australia Proteomics Market by Services and Software
    - 11.3.7.1.4 Australia Proteomics Market by Application
  - 11.3.7.2 China Proteomics Market
    - 11.3.7.2.1 China Proteomics Market by Instrument
    - 11.3.7.2.2 China Proteomics Market by Reagents
    - 11.3.7.2.3 China Proteomics Market by Services and Software
    - 11.3.7.2.4 China Proteomics Market by Application
  - 11.3.7.3 India Proteomics Market
    - 11.3.7.3.1 India Proteomics Market by Instrument
    - 11.3.7.3.2 India Proteomics Market by Reagents
    - 11.3.7.3.3 India Proteomics Market by Services and Software
    - 11.3.7.3.4 India Proteomics Market by Application
  - 11.3.7.4 Japan Proteomics Market
    - 11.3.7.4.1 Japan Proteomics Market by Instrument
    - 11.3.7.4.2 Japan Proteomics Market by Reagents
    - 11.3.7.4.3 Japan Proteomics Market by Services and Software
    - 11.3.7.4.4 Japan Proteomics Market by Application
  - 11.3.7.5 South Korea Proteomics Market
    - 11.3.7.5.1 South Korea Proteomics Market by Instrument
    - 11.3.7.5.2 South Korea Proteomics Market by Reagents
    - 11.3.7.5.3 South Korea Proteomics Market by Services and Software
    - 11.3.7.5.4 South Korea Proteomics Market by Application
  - 11.3.7.6 Rest of Asia-Pacific Proteomics Market
    - 11.3.7.6.1 Rest of Asia-Pacific Proteomics Market by Instrument
    - 11.3.7.6.2 Rest of Asia-Pacific Proteomics Market by Reagents
    - 11.3.7.6.3 Rest of Asia-Pacific Proteomics Market by Services and Software
    - 11.3.7.6.4 Rest of Asia-Pacific Proteomics Market by Application
11.4. MIDDLE EAST AND AFRICA
- 11.4.1 Middle East and Africa Proteomics Market Overview
- 11.4.2 Middle East and Africa Proteomics Market Forecasts and Analysis
- 11.4.3 Middle East and Africa Proteomics Market Forecasts and Analysis - By Instrument
- 11.4.4 Middle East and Africa Proteomics Market Forecasts and Analysis - By Reagents
- 11.4.5 Middle East and Africa Proteomics Market Forecasts and Analysis - By Services and Software
- 11.4.6 Middle East and Africa Proteomics Market Forecasts and Analysis - By Application
- 11.4.7 Middle East and Africa Proteomics Market Forecasts and Analysis - By Countries
  - 11.4.7.1 South Africa Proteomics Market
    - 11.4.7.1.1 South Africa Proteomics Market by Instrument
    - 11.4.7.1.2 South Africa Proteomics Market by Reagents
    - 11.4.7.1.3 South Africa Proteomics Market by Services and Software
    - 11.4.7.1.4 South Africa Proteomics Market by Application
  - 11.4.7.2 Saudi Arabia Proteomics Market
    - 11.4.7.2.1 Saudi Arabia Proteomics Market by Instrument
    - 11.4.7.2.2 Saudi Arabia Proteomics Market by Reagents
    - 11.4.7.2.3 Saudi Arabia Proteomics Market by Services and Software
    - 11.4.7.2.4 Saudi Arabia Proteomics Market by Application
  - 11.4.7.3 U.A.E Proteomics Market
    - 11.4.7.3.1 U.A.E Proteomics Market by Instrument
    - 11.4.7.3.2 U.A.E Proteomics Market by Reagents
    - 11.4.7.3.3 U.A.E Proteomics Market by Services and Software
    - 11.4.7.3.4 U.A.E Proteomics Market by Application
  - 11.4.7.4 Rest of Middle East and Africa Proteomics Market
    - 11.4.7.4.1 Rest of Middle East and Africa Proteomics Market by Instrument
    - 11.4.7.4.2 Rest of Middle East and Africa Proteomics Market by Reagents
    - 11.4.7.4.3 Rest of Middle East and Africa Proteomics Market by Services and Software
    - 11.4.7.4.4 Rest of Middle East and Africa Proteomics Market by Application
11.5. SOUTH AND CENTRAL AMERICA
- 11.5.1 South and Central America Proteomics Market Overview
- 11.5.2 South and Central America Proteomics Market Forecasts and Analysis
- 11.5.3 South and Central America Proteomics Market Forecasts and Analysis - By Instrument
- 11.5.4 South and Central America Proteomics Market Forecasts and Analysis - By Reagents
- 11.5.5 South and Central America Proteomics Market Forecasts and Analysis - By Services and Software
- 11.5.6 South and Central America Proteomics Market Forecasts and Analysis - By Application
- 11.5.7 South and Central America Proteomics Market Forecasts and Analysis - By Countries
  - 11.5.7.1 Brazil Proteomics Market
    - 11.5.7.1.1 Brazil Proteomics Market by Instrument
    - 11.5.7.1.2 Brazil Proteomics Market by Reagents
    - 11.5.7.1.3 Brazil Proteomics Market by Services and Software
    - 11.5.7.1.4 Brazil Proteomics Market by Application
  - 11.5.7.2 Argentina Proteomics Market
    - 11.5.7.2.1 Argentina Proteomics Market by Instrument
    - 11.5.7.2.2 Argentina Proteomics Market by Reagents
    - 11.5.7.2.3 Argentina Proteomics Market by Services and Software
    - 11.5.7.2.4 Argentina Proteomics Market by Application
  - 11.5.7.3 Rest of South and Central America Proteomics Market
    - 11.5.7.3.1 Rest of South and Central America Proteomics Market by Instrument
    - 11.5.7.3.2 Rest of South and Central America Proteomics Market by Reagents
    - 11.5.7.3.3 Rest of South and Central America Proteomics Market by Services and Software
    - 11.5.7.3.4 Rest of South and Central America Proteomics Market by Application

12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROTEOMICS MARKET

12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America

13. INDUSTRY LANDSCAPE

13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. PROTEOMICS MARKET, KEY COMPANY PROFILES

14.1. THERMO FISHER SCIENTIFIC INC.
- 14.1.1. Key Facts
- 14.1.2. Business Description
- 14.1.3. Products and Services
- 14.1.4. Financial Overview
- 14.1.5. SWOT Analysis
- 14.1.6. Key Developments
14.2. BIO-RAD LABORATORIES, INC.
- 14.2.1. Key Facts
- 14.2.2. Business Description
- 14.2.3. Products and Services
- 14.2.4. Financial Overview
- 14.2.5. SWOT Analysis
- 14.2.6. Key Developments
14.3. AGILENT TECHNOLOGIES
- 14.3.1. Key Facts
- 14.3.2. Business Description
- 14.3.3. Products and Services
- 14.3.4. Financial Overview
- 14.3.5. SWOT Analysis
- 14.3.6. Key Developments
14.4. DANAHER
- 14.4.1. Key Facts
- 14.4.2. Business Description
- 14.4.3. Products and Services
- 14.4.4. Financial Overview
- 14.4.5. SWOT Analysis
- 14.4.6. Key Developments
14.5. PERKINELMER INC.
- 14.5.1. Key Facts
- 14.5.2. Business Description
- 14.5.3. Products and Services
- 14.5.4. Financial Overview
- 14.5.5. SWOT Analysis
- 14.5.6. Key Developments
14.6. MERCK KGAA
- 14.6.1. Key Facts
- 14.6.2. Business Description
- 14.6.3. Products and Services
- 14.6.4. Financial Overview
- 14.6.5. SWOT Analysis
- 14.6.6. Key Developments
14.7. LUMINEX CORPORATION
- 14.7.1. Key Facts
- 14.7.2. Business Description
- 14.7.3. Products and Services
- 14.7.4. Financial Overview
- 14.7.5. SWOT Analysis
- 14.7.6. Key Developments
14.8. GENERAL ELECTRIC COMPANY
- 14.8.1. Key Facts
- 14.8.2. Business Description
- 14.8.3. Products and Services
- 14.8.4. Financial Overview
- 14.8.5. SWOT Analysis
- 14.8.6. Key Developments